These methods focus on the dose-dependent and spatiotemporal metabolite–drug interactions ... are also explored for their potential to enhance target discovery. With clear and detailed flow charts, ...

Nvidia Corporation's $3.3T market cap reflects its dominance in AI, robotics, and cloud computing. Read why I think NVDA ...

The new versions of BD flow cytometer instrument software compatible with Biosero automation software for the BD FACSymphony A1™ Cell Analyzer, BD FACSymphony™ A5 SE Cell Anal ...

BD and Biosero, announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.

Traditionally, several steps in a lab’s flow cytometry workflow for drug discovery and development require manual processes. With robotic integration, these steps can become automated.